RxTROSPECT tracks and maps key data-points from FDA oncology approvals. Our analytics platform collects information on the condition, indication, study design, pivotal study phase and size, regulatory pathways, designations and timelines. Access our platform to identify regulatory trends and precedent from over 300 oncology indications. Visit our website or contact us to unlock the power of analytics.
Looking for a particular RxTROSPECT employee's phone or email?
RxTROSPECT is based in Chicago, Illinois.